The present invention relates to compounds defined by formula (I) wherein the variables R1, R2, R3, m, and n are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are activators of the receptor GPR40 and thus are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.本發明係關於式(I)所定義之化合物其中變數R1、R2、R3、m及n係如請求項1中所定義,其具有有價值之藥理學活性。特定言之,該等化合物為受體GPR40之活化劑,且因此適用於治療及預防可受此受體影響之疾病,諸如代謝疾病,特別是2型糖尿病。
